Int J Biol Macromol. 2026 Jan 11. pii: S0141-8130(26)00125-X. [Epub ahead of print]340(Pt 2):
150199
Ocular drug delivery remains significantly challenging due to complex anatomical and physiological barriers, poor bioavailability, and inefficient drug absorption. These limitations highlight the requirement for advanced delivery systems to overcome the ocular barrier and enable efficacious therapeutic outcomes. This review explores the potential of marine-derived polysaccharides as innovative carriers for ocular applications, emphasizing their potential as drug-delivery mechanisms to enhance drug retention, permeation, and bioavailability through advanced nanoplatforms. Polysaccharides such as κ-carrageenan, agarose, alginate, chitosan, hyaluronic acid, heparan sulfate, and chondroitin sulfate possess physicochemical, biocompatible, biodegradable, and mucoadhesive properties, making them ideal materials for ocular drug delivery. Notably, marine-derived polysaccharides have been reported to significantly improve ocular delivery performance, achieving up to a 3-fold increase in corneal permeability, higher drug accumulation in the aqueous humor (>47% vs. ∼20%), and approximately 3.6-3.8-fold enhancement in precorneal retention, while also enabling intelligent systems such as pH- and light-responsive drug release. These polymers have been engineered into various delivery platforms, including nanoparticles, micelles, dendrimers, nanosuspensions, hydrogels, and implants. Such systems promote sustained (long-acting), targeted (site-specific), and intelligent (stimuli-responsive) drug release, thereby significantly enhancing precorneal retention and therapeutic efficacy. These approaches are particularly relevant for treating various corneal diseases, including glaucoma, diabetic retinopathy, ocular inflammation, and age-related macular degeneration. The article also emphasizes the potential of emerging strategies to transform ocular drug delivery by offering customizable, stimuli-responsive, and patient-friendly therapeutic options. However, further in-depth research is crucial to optimize formulations, evaluate long-term safety, and address regulatory challenges for successful clinical translation.
Keywords: Marine-derived polysaccharides; Ocular disorders; Pharmaceutical delivery technologies